Related Experiment Video
Updated: Mar 19, 2026
16:15
Mouse Kidney Transplantation: Models of Allograft Rejection
Published on: October 11, 2014
21.9K
Senescence in chronic allograft nephropathy
María Del Pilar Sosa Peña1, Reynold Lopez-Soler2, J Andrés Melendez1
1SUNY Polytechnic Institute, Colleges of Nanoscale Science and Engineering, Albany, New York.
American Journal of Physiology. Renal Physiology
|June 17, 2016
Summary
Chronic allograft nephropathy (CAN) is a major cause of kidney transplant failure. This review explores how cellular senescence, via the senescence-associated secretory phenotype (SASP), contributes to CAN development and suggests research directions for improved graft survival.
Area of Science:
- Nephrology
- Immunology
- Cell Biology
Background:
- Kidney transplantation is limited by static graft survival rates despite advances in immunosuppression.
- Chronic allograft nephropathy (CAN) is the primary cause of long-term kidney transplant failure.
- Understanding CAN mechanisms is vital for improving post-transplant outcomes.
Purpose of the Study:
- To explore the link between cellular senescence, the senescence-associated secretory phenotype (SASP), and epithelial to mesenchymal transition (EMT) in the development of CAN.
- To highlight the role of interleukin-1 alpha (IL-1α) and reactive oxygen species (ROS) in this process.
- To propose future research avenues for enhancing kidney allograft survival.
Main Methods:
- Review of existing literature on cellular senescence, SASP, EMT, and CAN.
- Analysis of the molecular pathways connecting these processes, including IL-1α and ROS.
- Identification of potential therapeutic targets based on mechanistic understanding.
Main Results:
- Cellular senescence in proximal tubules is implicated as an early step in CAN development.
- SASP, driven by ROS, releases inflammatory mediators like IL-1α, promoting EMT.
- This cascade contributes significantly to the progressive decline of renal allograft function.
Conclusions:
- Targeting cellular senescence, SASP, or ROS may offer novel strategies to prevent or treat CAN.
- Further research into these pathways is crucial for improving long-term kidney transplant outcomes.
- Interventions aimed at mitigating senescence-induced inflammation could enhance graft longevity.
Related Concept Videos
01:25Chronic Kidney Disease I: Introduction
1000
Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
1000
01:29Acute Kidney Injury III: Clinical Manifestations
1.3K
Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
1.3K
01:24Nephrotic Syndrome I : Introduction
852
Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of...
852
01:28Kidney Transplant I: Introduction
666
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
666
01:24Chronic Kidney Disease II: Clinical Manifestations
897
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
897
01:26Kidney Transplant II: Surgical Procedure
718
Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living...
718